Cargando…

Clinical Assessment of PTEN Loss in Endometrial Carcinoma: Immunohistochemistry Out-Performs Gene Sequencing

PTEN is a tumor suppressor that negatively regulates the PI3K-AKT signaling pathway, which is implicated in the pathogenesis of endometrial carcinoma. Sanger sequencing has been considered to be the gold standard for detection of PTEN sequence abnormalities. However, this approach fails to address t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Djordjevic, Bojana, Hennessy, Bryan T., Li, Jie, Barkoh, Bedia A., Luthra, Rajyalakshmi, Mills, Gordon B., Broaddus, Russell R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341518/ https://www.ncbi.nlm.nih.gov/pubmed/22301702 http://dx.doi.org/10.1038/modpathol.2011.208

Ejemplares similares

Relationship between PTEN, DNA Mismatch Repair, and Tumor Histotype in Endometrial Carcinoma: Retained Positive Expression of PTEN Preferentially Identifies Sporadic Non-Endometrioid Carcinomas
por: Djordjevic, Bojana, et al.
Publicado: (2013)

Targeted Next-Generation Sequencing of Endometrial Cancer and Matched Circulating Tumor DNA: Identification of Plasma-Based, Tumor-Associated Mutations in Early Stage Patients
por: Bolivar, Ana M., et al.
Publicado: (2018)

Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors
por: Mehrotra, Meenakshi, et al.
Publicado: (2017)

Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory
por: Mehrotra, Meenakshi, et al.
Publicado: (2017)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression
por: Kim, Tae Hoon, et al.
Publicado: (2010)

Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry
por: Aguilar, Mitzi, et al.
Publicado: (2022)

The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action
por: Kim, Tae Hoon, et al.
Publicado: (2010)

The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten
por: Liang, Xiaohuan, et al.
Publicado: (2018)

PTEN Sequence Analysis in Endometrial Hyperplasia and Endometrial Carcinoma in Slovak Women
por: Gbelcová, H., et al.
Publicado: (2015)

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
por: Kurnit, Katherine C., et al.
Publicado: (2017)

Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas
por: Akiyama-Abe, A, et al.
Publicado: (2013)

Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling
por: Williams, Erin, et al.
Publicado: (2017)

Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison to PTEN FISH
por: Lotan, Tamara L., et al.
Publicado: (2016)

Hysteroscopic endometrial biopsy with immunohistochemistry in the diagnosis of endometritis
por: Zhang, Yan, et al.
Publicado: (2021)

Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing
por: Sabir, Sharjeel H., et al.
Publicado: (2017)

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
por: Liang, Han, et al.
Publicado: (2012)

Mechanisms of mutant β-catenin in endometrial cancer progression
por: Parrish, Molly L., et al.
Publicado: (2022)

Identification of a Subset of Microsatellite-Stable Endometrial Carcinoma with High PD-L1 and CD8+ Lymphocytes
por: Crumley, Suzanne, et al.
Publicado: (2018)

OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets
por: Madden, Stephen F, et al.
Publicado: (2014)

Pten loss results in inappropriate excitatory connectivity
por: Skelton, Patrick D., et al.
Publicado: (2019)

Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges
por: Luthra, Rajyalakshmi, et al.
Publicado: (2015)

Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss
por: Yoshida, Akihiro, et al.
Publicado: (2022)

Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro
por: Aslan, Ozlem, et al.
Publicado: (2018)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility
por: Köbel, Martin, et al.
Publicado: (2019)

Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features
por: Kang, Eun Young, et al.
Publicado: (2021)

Steroid Hormone Intervenes in the Endometrial Tumorigenesis of Pten Ablation
por: Kim, Hong Im, et al.
Publicado: (2013)

WWP2 and its association with PTEN in endometrial cancer
por: Clements, Aine E., et al.
Publicado: (2015)

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry
por: Gallego, Oscar, et al.
Publicado: (2013)

MUC1 stimulates EGFR expression and function in endometrial cancer
por: Engel, Brian J., et al.
Publicado: (2016)

Erratum to: Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry
por: Gallego, Oscar, et al.
Publicado: (2014)

Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer
por: Dedeurwaerdere, Franceska, et al.
Publicado: (2021)

In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity
por: Ágoston, Emese Irma, et al.
Publicado: (2016)

The PTEN, BAX, and IGFIIR Genes Are Mutated in Endometrial Atypical Hyperplasia
por: Yoshinaga, Kousuke, et al.
Publicado: (1998)

Analysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ Malignancies
por: Chen, Hui, et al.
Publicado: (2015)

Nuclear β-Catenin Localization and Mutation of the CTNNB1 Gene: A Context-Dependent Association
por: Kim, Grace, et al.
Publicado: (2018)

Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11)
por: Mundhada, Shailendra, et al.
Publicado: (2004)

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
por: Vermij, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_985vfsvgjejgqffnokem1ln65b